Clinical Trial Cancer Mission 2020 Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 28, 2015)
Clinical Trial Cancer Mission 2020 Act
Amends the Public Health Service Act to revise clinical trial registry data bank provisions to specify that a device or drug clinical trial must be included in the clinical trial registry data bank regardless of whether it results in a positive or negative outcome.
Requires the responsible party of any clinical trials funded in whole or in part by the Department of Defense (DOD) to certify in all required grant or progress forms that the required submissions to the clinical trial registry data bank have been made. Requires DOD to verify that the clinical trial information has been submitted before releasing any remaining grant funds or funding future grants.
Makes a clinical trial grantee of the Department of Health and Human Services or DOD who fails to submit the required information to the data bank ineligible for the remaining grant funds or future funds. Makes the grantee liable for repayment of grant amounts already provided.
What just happenedJan 30, 2015
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJan 28, 2015
- Jan 30, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 28, 2015IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 28, 2015IntroReferralIntro-H
Introduced in House
- Jan 28, 2015IntroReferral1000
Introduced in House